Clinical trial NCT03036189: Improving Chronic Illness Management With the Apsaalooke Nation: The Baa Nnilah Project
Official title: Improving Chronic Illness Management With the Apsaalooke Nation: The Baa Nnilah Project
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Chronic Disease
Lead sponsor: Montana State University
Sponsor class: OTHER
Collaborators: name: National Institutes of Health (NIH)
name: University of Nevada, Las Vegas
name: National Institute on Minority Health and Health Disparities (NIMHD)
First posted: 2017-01-30
Enrollment: 211
Sex: ALL
Minimum age (years): 25
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: delayed control group design
Primary purpose: TREATMENT

Brief summary: This is a group randomized trial of an intervention to improve chronic illness self-management.


Eligibility criteria: Inclusion Criteria:

* ≥ 25 years
* AI
* diagnosed with diabetes
* hypertension
* osteoporosis
* liver disease
* chronic lung disease (asthma, chronic bronchitis or emphysema)
* heart disease (coronary artery disease or congestive heart failure)
* stroke (completed cerebrovascular accident with neurologic handicap and normal mentation)
* chronic arthritis

Exclusion Criteria:

* major medical illness that precludes their attendance at 7 meetings
* \<25 years of age

Primary outcomes:
measure: SF-12 - Physical Health
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: SF-12 - Mental Health
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
Secondary outcomes:
measure: Patient Health Questionnaire-9
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: PROMIS Satisfaction With Social Roles and Activities
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: PROMIS Self-Efficacy for Managing Symptoms
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: PROMIS Emotional Support
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: PROMIS Positive Affect and Well-being
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: PROMIS Physical Function
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: PROMIS Self-efficacy for Managing Emotions
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: PROMIS Self-efficacy for Managing Social Interactions
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: Patient Activation Measure
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: Modified Timed Up and Go
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: Modified Balance Error Scoring System
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
measure: 6-minute Walk
timeFrame: Intervention group: baseline (T1), up to 1 month (T2), up to 8 months (T3), up to 13 months (T4). WLC group pre-baseline (T1), baseline (T2), up to 1 month (T3), up to 9 months (T4), up to 13 months (T5)
Other outcomes:
Locations:
city: Crow Agency
country: United States
facility: Messengers for Health
state: Montana
Study officials:
affiliation: Montana State University
name: Suzanne Held, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes. 2007 Sep 7;5:54. doi: 10.1186/1477-7525-5-54.
citation: Hallett J, Feng D, McCormick AKHG, Allen S, Inouye J, Schure M, Holder S, Medicine LO, Held S. Improving Chronic Illness Self-Management with the Apsaalooke Nation: The Baa nnilah Project, a cluster randomized trial protocol. Contemp Clin Trials. 2022 Aug;119:106835. doi: 10.1016/j.cct.2022.106835. Epub 2022 Jun 18.
citation: Allen S, Held S, Milne-Price S, McCormick A, Feng D, Inouye J, Schure M, Castille D, Howe RB, Pitts M, Keene S, Belone L, Wallerstein N. Community sharing: Contextualizing Western research notions of contamination within an Indigenous research paradigm. Am J Community Psychol. 2022 Mar;69(1-2):145-156. doi: 10.1002/ajcp.12552. Epub 2021 Sep 17.
citation: Rink E, Knight K, Ellis C, McCormick A, FireMoon P, Held S, Webber E, Adams A. Using Community-Based Participatory Research to Design, Conduct, and Evaluate Randomized Controlled Trials with American Indian Communities. Prev Chronic Dis. 2020 Nov 12;17:E143. doi: 10.5888/pcd17.200099.